{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:31:34Z","timestamp":1777959094368,"version":"3.51.4"},"reference-count":49,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:p>Epigenetic regulation is an important factor in glucose metabolism, but underlying mechanisms remain largely unknown. Here we investigated epigenetic control of systemic metabolism by bromodomain-containing proteins (Brds), which are transcriptional regulators binding to acetylated histone, in both intestinal cells and mice treated with the bromodomain inhibitor JQ-1. In vivo treatment with JQ-1 resulted in hyperglycemia and severe glucose intolerance. Whole-body or tissue-specific insulin sensitivity was not altered by JQ-1; however, JQ-1 treatment reduced insulin secretion during both in vivo glucose tolerance testing and ex vivo incubation of isolated islets. JQ-1 also inhibited expression of fibroblast growth factor (FGF) 15 in the ileum and decreased FGF receptor 4\u2013related signaling in the liver. These adverse metabolic effects of Brd4 inhibition were fully reversed by in vivo overexpression of FGF19, with normalization of hyperglycemia. At a cellular level, we demonstrate Brd4 binds to the promoter region of FGF19 in human intestinal cells; Brd inhibition by JQ-1 reduces FGF19 promoter binding and downregulates FGF19 expression. Thus, we identify Brd4 as a novel transcriptional regulator of intestinal FGF15\/19 in ileum and FGF signaling in the liver and a contributor to the gut-liver axis and systemic glucose metabolism.<\/jats:p>","DOI":"10.2337\/db21-0574","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T15:09:53Z","timestamp":1643641793000},"page":"1023-1033","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":8,"title":["Bromodomain Inhibition Reveals FGF15\/19 As a Target of Epigenetic Regulation and Metabolic Control"],"prefix":"10.2337","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9567-8361","authenticated-orcid":false,"given":"Chisayo","family":"Kozuka","sequence":"first","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vissarion","family":"Efthymiou","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicencia M.","family":"Sales","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soravis","family":"Osataphan","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixing","family":"Yuchi","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Chimene-Weiss","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Mulla","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Isganaitis","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Desmond","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzuka","family":"Sanechika","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Kusuyama","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Goodyear","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Shi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA"},{"name":"Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Gerszten","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA"},{"name":"Cardiology Division, Beth Israel Deaconess Medical Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5402-1382","authenticated-orcid":false,"given":"Cristina","family":"Aguayo-Mazzucato","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Carapeto","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvania DaSilva","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado, Denver, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-3278","authenticated-orcid":false,"given":"Darleen","family":"Sandoval","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado, Denver, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Direna","family":"Alonso-Curbelo","sequence":"additional","affiliation":[{"name":"Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA"},{"name":"Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA"},{"name":"Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-3429","authenticated-orcid":false,"given":"Mary-Elizabeth","family":"Patti","sequence":"additional","affiliation":[{"name":"Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"2022042018442190000_B1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2337\/db18-0537","article-title":"Epigenetics and epigenomics: implications for diabetes and obesity","volume":"67","author":"Rosen","year":"2018","journal-title":"Diabetes"},{"key":"2022042018442190000_B2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrm3931","article-title":"50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond","volume":"16","author":"Verdin","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022042018442190000_B3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng829","article-title":"Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice","volume":"30","author":"Yamauchi","year":"2002","journal-title":"Nat Genet"},{"key":"2022042018442190000_B4","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.celrep.2016.08.005","article-title":"Disruption of the class IIa HDAC corepressor complex increases energy expenditure and lipid oxidation","volume":"16","author":"Gaur","year":"2016","journal-title":"Cell Rep"},{"key":"2022042018442190000_B5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nm.4245","article-title":"Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion","volume":"23","author":"Hong","year":"2017","journal-title":"Nat Med"},{"key":"2022042018442190000_B6","doi-asserted-by":"crossref","first-page":"a018762","DOI":"10.1101\/cshperspect.a018762","article-title":"Writers and readers of histone acetylation: structure, mechanism, and inhibition","volume":"6","author":"Marmorstein","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2022042018442190000_B7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20090928","article-title":"Brd2 disruption in mice causes severe obesity without Type 2 diabetes","volume":"425","author":"Wang","year":"2009","journal-title":"Biochem J"},{"key":"2022042018442190000_B8","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41467-017-02403-5","article-title":"Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"2022042018442190000_B9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/MCB.01365-08","article-title":"Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA","volume":"29","author":"Huang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"2022042018442190000_B10","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ncb2324","article-title":"NF-\u03baB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration","volume":"13","author":"Mauro","year":"2011","journal-title":"Nat Cell Biol"},{"key":"2022042018442190000_B11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molcel.2016.08.023","article-title":"Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations","volume":"64","author":"Barrow","year":"2016","journal-title":"Mol Cell"},{"key":"2022042018442190000_B12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.celrep.2014.08.025","article-title":"Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibition","volume":"8","author":"Bolden","year":"2014","journal-title":"Cell Rep"},{"key":"2022042018442190000_B13","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/dbi17-0007","article-title":"Targeting FXR and FGF19 to treat metabolic diseases-lessons learned from bariatric surgery","volume":"67","author":"Bozadjieva","year":"2018","journal-title":"Diabetes"},{"key":"2022042018442190000_B14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2337\/dc16-0351","article-title":"Roles of the gut in glucose homeostasis","volume":"39","author":"Holst","year":"2016","journal-title":"Diabetes Care"},{"key":"2022042018442190000_B15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"2022042018442190000_B16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2022042018442190000_B17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1101\/sqb.2011.76.010710","article-title":"Roles of FGF19 in liver metabolism","volume":"76","author":"Kir","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"2022042018442190000_B18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.semcdb.2015.09.021","article-title":"Metabolic fibroblast growth factors (FGFs): mediators of energy homeostasis","volume":"53","author":"Markan","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"2022042018442190000_B19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"2022042018442190000_B20","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1172\/JCI70710","article-title":"FGF19 action in the brain induces insulin-independent glucose lowering","volume":"123","author":"Morton","year":"2013","journal-title":"J Clin Invest"},{"key":"2022042018442190000_B21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"2022042018442190000_B22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmet.2017.12.003","article-title":"A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus","volume":"8","author":"Liu","year":"2018","journal-title":"Mol Metab"},{"key":"2022042018442190000_B23","first-page":"390","article-title":"Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome","volume":"41","author":"Barutcuoglu","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"2022042018442190000_B24","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s11695-019-03845-0","article-title":"Plasma FGF-19 levels are increased in patients with post-bariatric hypoglycemia","volume":"29","author":"Mulla","year":"2019","journal-title":"Obes Surg"},{"key":"2022042018442190000_B25","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/en.2017-00288","article-title":"Attenuated effects of bile acids on glucose metabolism and insulin sensitivity in a male mouse model of prenatal undernutrition","volume":"158","author":"Ma","year":"2017","journal-title":"Endocrinology"},{"key":"2022042018442190000_B26","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/s41467-021-24914-y","article-title":"Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice","volume":"12","author":"Bozadjieva-Kramer","year":"2021","journal-title":"Nat Commun"},{"key":"2022042018442190000_B27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1194\/jlr.M089961","article-title":"Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis","volume":"60","author":"Zhou","year":"2019","journal-title":"J Lipid Res"},{"key":"2022042018442190000_B28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrg2825","article-title":"Tackling the widespread and critical impact of batch effects in high-throughput data","volume":"11","author":"Leek","year":"2010","journal-title":"Nat Rev Genet"},{"key":"2022042018442190000_B29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2105-7-261","article-title":"Empirical array quality weights in the analysis of microarray data","volume":"7","author":"Ritchie","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"2022042018442190000_B30","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2022042018442190000_B31","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/bioinformatics\/btq401","article-title":"ROAST: rotation gene set tests for complex microarray experiments","volume":"26","author":"Wu","year":"2010","journal-title":"Bioinformatics"},{"key":"2022042018442190000_B32","doi-asserted-by":"crossref","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The reactome pathway knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2022042018442190000_B33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"key":"2022042018442190000_B34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature14898","article-title":"Transcriptional plasticity promotes primary and acquired resistance to BET inhibition","volume":"525","author":"Rathert","year":"2015","journal-title":"Nature"},{"key":"2022042018442190000_B35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"2022042018442190000_B36","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1038\/s41598-017-12342-2","article-title":"BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene","volume":"7","author":"Sakurai","year":"2017","journal-title":"Sci Rep"},{"key":"2022042018442190000_B37","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb3002s98","article-title":"Targeted metabolomics","author":"Roberts","year":"2012","journal-title":"Curr Protoc Mol Biol"},{"key":"2022042018442190000_B38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13059-015-0835-6","article-title":"Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2","volume":"16","author":"Kim","year":"2015","journal-title":"Genome Biol"},{"key":"2022042018442190000_B39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: the FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig Dis"},{"key":"2022042018442190000_B40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","article-title":"Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism","volume":"3","author":"Marcelin","year":"2013","journal-title":"Mol Metab"},{"key":"2022042018442190000_B41","doi-asserted-by":"crossref","first-page":"20390","DOI":"10.1038\/srep20390","article-title":"Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains","volume":"6","author":"Nakagawa","year":"2016","journal-title":"Sci Rep"},{"key":"2022042018442190000_B42","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00018-011-0714-6","article-title":"Paneth cell \u03b1-defensins in enteric innate immunity","volume":"68","author":"Ouellette","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"2022042018442190000_B43","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cmet.2013.04.007","article-title":"Diet1 functions in the FGF15\/19 enterohepatic signaling axis to modulate bile acid and lipid levels","volume":"17","author":"Vergnes","year":"2013","journal-title":"Cell Metab"},{"key":"2022042018442190000_B44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI83265","article-title":"CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer","volume":"126","author":"McCleland","year":"2016","journal-title":"J Clin Invest"},{"key":"2022042018442190000_B45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"ENCODE Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2022042018442190000_B46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","article-title":"FGF19, FGF21, and an FGFR1\/\u03b2-klotho-activating antibody act on the nervous system to regulate body weight and glycemia","volume":"26","author":"Lan","year":"2017","journal-title":"Cell Metab"},{"key":"2022042018442190000_B47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2337\/diabetes.54.3.702","article-title":"Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model","volume":"54","author":"Jimenez-Chillaron","year":"2005","journal-title":"Diabetes"},{"key":"2022042018442190000_B48","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.3390\/ijms20194776","article-title":"BET proteins are required for transcriptional activation of the senescent islet cell secretome in type 1 diabetes","volume":"20","author":"Thompson","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022042018442190000_B49","doi-asserted-by":"crossref","first-page":"e141640","DOI":"10.1172\/jci.insight.141640","article-title":"BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination","volume":"6","author":"Jung","year":"2020","journal-title":"JCI Insight"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/71\/5\/1023\/673003\/db210574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/71\/5\/1023\/673003\/db210574.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:43:54Z","timestamp":1667393034000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/71\/5\/1023\/141029\/Bromodomain-Inhibition-Reveals-FGF15-19-As-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,1,31]]},"published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db21-0574","relation":{"has-preprint":[{"id-type":"doi","id":"10.2337\/figshare.19064309.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2019.12.11.872887","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.19064309","asserted-by":"object"}]},"ISSN":["0012-1797"],"issn-type":[{"value":"0012-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}